LINC02172

Across TCGA pan-cancer cohorts, LINC02172 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC02172’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02172 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02172 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC, KICH, and KIRP are the cancer types where LINC02172 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02172 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−0.981	<.001	10	view →
KICH	Male	All	−1.675	<.001	6	view →
KIRP	All	All	−0.484	.002	6	view →
BRCA	All	III,IV	−0.238	<.001	6	view →
STAD	All	IV	+0.096	.004	3	view →
THCA	All	IV	−0.075	.025	3	view →
UCEC	All	IV	+0.065	.049	2	view →
LUSC	All	All	−0.055	.001	2	view →
LUAD	Female	III,IV	−0.078	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

LINC02172–KIRC

Open the KIRC breakdown →